'Tamper-evident' benefits are evident

28 Feb 2019

2019 will mark Uniplast's debut at this year's edition of CPhI Worlwide in Frankfurt, where it will showcase its expertise in plastic packaging.

Pharmaceutical packaging serves numerous purposes and comes in a variety of materials and designs, depending on the drug product.

'Tamper-evident' benefits are evident

Uniplast - a regional leader in the manufacture and distribution of pharmaceutical, medical and cosmetic packaging - has used its 27 years of operational expertise and knowhow to develop more than 150 different high-quality products.

Tamper-proof bottles that save time and reduce contamination

The company is renowned for its variety of plastic packaging, particularly its bottles with a tamper-proof cap and integrated dropper, which reduces the packaging process from three to two steps, thereby saving time in product filling and packing, and reduces the risk of contamination while handling the sterile products. These plastic bottles are used for storing liquid pharmaceutical products (magistral medicine, galenical medicine, ready-made medicines, and pharmaceutical substance) and can be in direct contact with the product. Customers can choose the colour of the container

Compliance and certification

Demonstrating its compliance with various regulatory standards, Uniplast's plastic containers and closures are manufactured in accordance with the following: ISO 9001, ISO 14001, OHSAS 18001 and ISO 15378. In 2017, Uniplast implemented ISO 13485, regarding the production, development and sale of sterile and nonsterile IVDs, urine cups, Petri dishes, and swab and faeces containers.

The Uniplast team's creative environment motivates and inspires all those that are in touch with their products and services. Uniplast customers can expect a relationship based on 100% trust and fair co-operation to ensure superior quality products that will improve their sales and facilitate the way to success.

Read More

Related news

All Recipharm facilities ready for EU serialisation, regardless of Brexit

All Recipharm facilities ready for EU serialisation, regardless of Brexit

15 Feb 2019

The CDMO invested EUR 35 million into its operations and launched a 3-year programme to provide a compliant serialisation solution for its customers.

Read more 
Brexit - the EU FMD's painful problem

Brexit - the EU FMD's painful problem

7 Feb 2019

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Read more 
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

27 Jan 2019

New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes.

Read more 
New API screening program strengthens Particle Sciences' nanomilling offering

New API screening program strengthens Particle Sciences' nanomilling offering

22 Jan 2019

Advanced formulation techniques such as nanomilling may provide an excellent route to improved bioavailability and enhanced therapeutic effect.

Read more 
Univercells introduces breakthrough vaccine manufacturing platform

Univercells introduces breakthrough vaccine manufacturing platform

13 Jan 2019

The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint.

Read more 
BMS and Celgene merge to create premier innovative biopharma company

BMS and Celgene merge to create premier innovative biopharma company

3 Jan 2019

Significantly expands Phase III assets with six expected near-term product launches, representing greater than $15 billion in revenue potential.

Read more 
An increased risk of a hard or ‘no deal Brexit?

An increased risk of a hard or ‘no deal Brexit?

24 Dec 2018

A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business.

Read more 
One month on: medical cannabis is still taboo despite change in law

One month on: medical cannabis is still taboo despite change in law

11 Dec 2018

Restrictive guidelines have led many to buy CBD products online, leading to a boom in production with many products going to market without sufficient quality control.

Read more 
EU FMD - time is running out!

EU FMD - time is running out!

13 Nov 2018

Companies that have left it too late to implement their own solution will have to rely on support from providers, whose resources are already in high demand as the deadline approaches.

Read more 
Proprietary nasal delivery formulation of diazepam reaches NDA

Proprietary nasal delivery formulation of diazepam reaches NDA

7 Nov 2018

The absolute bioavailability of the Valtoco intranasal formulation was 96% of intravenous diazepam in a Phase I cross-over trial.

Read more